The results obtained with isolation perfusions in stage IIIA-IIIAB melanoma patients, performed at 42.5–43 °C for 2.5 h, are reported. These temperatures and perfusion times were chosen on the basis of experimental data in animal models and in vitro. The clinical results were impressive, but the high percentage of complications and the high cost from a social and human point of view make this experience negative with regard to its clinical applicability, at least with such a high temperature and long perfusion time.
Get full access to this article
View all access options for this article.
References
1.
CavaliereR., MondovìB., MoriccaG. and 11 others: Trattamento ipertermico dei tumori: basi biochimiche, applicazioni sperimentali, risultati clinici. In: L'ipertermici in Terapia Oncologica, BistolfiF. (Ed.), Piccin, Padova, 1981.
2.
CavaliereR., Di FilippoF., MoriccaG., CavallaroA.: Hyperthermia treatment of melanoma of the limbs: the present status of knowledge. IIIrd Meeting of the European Group of Hyperthermia in Radiation Oncology. October 1981, Rotterdam.
GiovannellaB.C., StehlinJ.S., MorganA.C.: Selective lethal aspects of supranormal temperature on human neoplastic cells.Cancer Res., 36: 3944–3950, 1976.
5.
GrossP., ParsonsP.G.: The effect of hyperthermia and melphalan on survival of human fibroblast strain and melanoma cell lines.Cancer Res., 37: 152–156, 1977.
6.
KrementzE.T., CaterR.D., SutherlandC., RyanR.F.: Malignant Melanoma of the Limbs: An Evaluation of Chemotherapy by Regional Perfusion. pp. 375, Year Book Medical, Chicago, 1976.
7.
MartjinH., OldhoffJ., Schraffordt KoopsH.: Regional perfusion in the treatment of patients with a locally metastasized malignant melanoma of the limbs.Eur. J. Cancer, 17: 471–476, 1981.
8.
McBrideC.R., SwearbakerE.V., HickeyR.C.: Prophylactic isolation perfusion as the primary treatment for invasive malignant melanoma of the limbs.Ann. Surg., 182: 316–321, 1975.
9.
OvergaardJ.: Fractionated reaction and hyperthermia.Experimental and clinical studies. Cancer, 48: 1116–1123, 1981.
10.
Schraffordt KoopsH., OldhoffJ., Van der PloegR., VermeyA., BelchuisH.: Some aspects of the treatment of primary melanoma of the extremities by isolated regional perfusion.Cancer, 39: 27–37, 1977.
11.
StehlinJ.S.Jr., ClarkR.L.: Experienec with regional chemotherapy.Arch. Surg., 85: 84, 1962.
12.
StehlinJ.S.Jr., ClarkR.L.: Melanoma of the extremities: Experience with conventional treatment and perfusion in 339 cases.Ann. Surg., 110: 366, 1965.
13.
StehlinS., GiovannellaB.C., De IpolyiD., MuenzL.R., AndersonR.F.: Results of hyperthermic perfusion for melanoma of the extremities.Surg. Gynecol. Obstet., 140: 339–348, 1975.
14.
StehlinJ.S., GiovannellaB.C., De IpolyiP.D., AndersonR.F.: Results of eleven years experience with heated perfusion for melanoma of the extremities.Cancer Res., 39: 2255–2257, 1979.
15.
StormF.K., HarrisonW.H., ElliotR.S., MortonD.L.: Normal tissue and solid tumor effect of hyperthermia in animal models and clinical trials.Cancer Res., 39: 2245–2251, 1979.
16.
SuitH.D., PhilD.: Hyperthermic effects on animal tissues.Radiology, 123: 483–487, 1977.
